GPL Holdings, Inc.

GPL Holdings, Inc. is a biopharmaceutical company engaged in developing novel therapies and supplying affordable healthcare items, including prescription and over-the-counter pharmaceuticals, medical and dental equipment, and healthcare supplies. Operating through its subsidiary, Global Pharma Labs, Inc., the company focuses on advancing its preclinical osteoarthritis therapy, OA-sys, toward clinical trials. In addition, it develops medication therapies targeting conditions such as onychomycosis, erectile dysfunction, cold sores, shingles, and genital herpes. The enterprise aims to serve healthcare consumers and distribution channels requiring affordable treatment options.

The company maintains its executive office space rent-free in San Leandro, California. It does not own or lease real estate properties and employs a single scientific advisor. Geographically, the business pursues licensing and product distribution initiatives internationally in Zambia through an agreement with Vitan Dandum Global Pharma Labs Limited, while also preparing to seek wholesale and retail pharmacy operating licenses within the state of California.

Summary of the business section of GPL's latest annual report, written by StockData.